You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Cereno Scientific, Webcast, Update on CS1 Phase 2 clinical study, 2022
By Inderes
Speaker: Sten R. Sörensen CEO, Dr Björn Dahlöf CMO, Dr Raymond Benza Prof. of Medicine & Director for Cardiovascular Diseases at Wexner Medical Center, Ohio State University, Dr Philip Adamson Divisional VP and CMO Abbott Heart Failure Division
Sector: Health care - Pharmaceuticals & Biotechnology
Activity: Webcast
Language: English